Pre-order Enquiry
Request Free Sample
Global Induced Pluripotent Stem Cells (iPSCs) Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-16156996 | Publishing Date : 17-Aug-2020
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Induced Pluripotent Stem Cells (iPSCs) Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Induced Pluripotent Stem Cells (iPSCs)1.1 Induced Pluripotent Stem Cells (iPSCs) Market Overview
1.1.1 Induced Pluripotent Stem Cells (iPSCs) Product Scope
1.1.2 Market Status and Outlook
1.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2015-2026)
1.4 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Region (2015-2020)
1.5 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026)
1.6.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026)
1.6.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026)
1.6.4 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026)
2 Induced Pluripotent Stem Cells (iPSCs) Market Overview by Type
2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Type (2015-2020)
2.3 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2021-2026)
2.4 Human iPSCs
2.5 Mouse iPSCs
3 Induced Pluripotent Stem Cells (iPSCs) Market Overview by Application
3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Application (2015-2020)
3.3 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2021-2026)
3.4 Academic Research
3.5 Drug Development and Discovery
3.6 Toxicity Screening
3.7 Regenerative Medicine
3.8 Others
4 Global Induced Pluripotent Stem Cells (iPSCs) Competition Analysis by Players
4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2019)
4.3 Date of Key Manufacturers Enter into Induced Pluripotent Stem Cells (iPSCs) Market
4.4 Global Top Players Induced Pluripotent Stem Cells (iPSCs) Headquarters and Area Served
4.5 Key Players Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service
4.6 Competitive Status
4.6.1 Induced Pluripotent Stem Cells (iPSCs) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Fujifilm Holding Corporation (CDI)
5.1.1 Fujifilm Holding Corporation (CDI) Profile
5.1.2 Fujifilm Holding Corporation (CDI) Main Business
5.1.3 Fujifilm Holding Corporation (CDI) Products, Services and Solutions
5.1.4 Fujifilm Holding Corporation (CDI) Revenue (US$ Million) & (2015-2020)
5.1.5 Fujifilm Holding Corporation (CDI) Recent Developments
5.2 Ncardia
5.2.1 Ncardia Profile
5.2.2 Ncardia Main Business and Company’s Total Revenue
5.2.3 Ncardia Products, Services and Solutions
5.2.4 Ncardia Revenue (US$ Million) (2015-2020)
5.2.5 Ncardia Recent Development and Reaction to Covid-19
5.3 Sumitomo Dainippon Pharma
5.5.1 Sumitomo Dainippon Pharma Profile
5.3.2 Sumitomo Dainippon Pharma Main Business
5.3.3 Sumitomo Dainippon Pharma Products, Services and Solutions
5.3.4 Sumitomo Dainippon Pharma Revenue (US$ Million) & (2015-2020)
5.3.5 Astellas Pharma Inc Recent Developments
5.4 Astellas Pharma Inc
5.4.1 Astellas Pharma Inc Profile
5.4.2 Astellas Pharma Inc Main Business
5.4.3 Astellas Pharma Inc Products, Services and Solutions
5.4.4 Astellas Pharma Inc Revenue (US$ Million) & (2015-2020)
5.4.5 Astellas Pharma Inc Recent Developments
5.5 Fate Therapeutics, Inc
5.5.1 Fate Therapeutics, Inc Profile
5.5.2 Fate Therapeutics, Inc Main Business
5.5.3 Fate Therapeutics, Inc Products, Services and Solutions
5.5.4 Fate Therapeutics, Inc Revenue (US$ Million) & (2015-2020)
5.5.5 Fate Therapeutics, Inc Recent Developments
5.6 Pluricell Biotech
5.6.1 Pluricell Biotech Profile
5.6.2 Pluricell Biotech Main Business
5.6.3 Pluricell Biotech Products, Services and Solutions
5.6.4 Pluricell Biotech Revenue (US$ Million) & (2015-2020)
5.6.5 Pluricell Biotech Recent Developments
5.7 Cell Inspire Biotechnology
5.7.1 Cell Inspire Biotechnology Profile
5.7.2 Cell Inspire Biotechnology Main Business and Company’s Total Revenue
5.7.3 Cell Inspire Biotechnology Products, Services and Solutions
5.7.4 Cell Inspire Biotechnology Revenue (US$ Million) (2015-2020)
5.7.5 Cell Inspire Biotechnology Recent Development and Reaction to Covid-19
5.8 ReproCELL
5.8.1 ReproCELL Profile
5.8.2 ReproCELL Main Business
5.8.3 ReproCELL Products, Services and Solutions
5.8.4 ReproCELL Revenue (US$ Million) & (2015-2020)
5.8.5 ReproCELL Recent Developments
6 North America
6.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Induced Pluripotent Stem Cells (iPSCs) Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Induced Pluripotent Stem Cells (iPSCs) Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026
Table 2. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2015-2020) (US$ Million)
Table 3. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Region (2015-2020)
Table 4. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Region (2021-2026) (US$ Million)
Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size Share by Region (2021-2026)
Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026
Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (US$ Million)
Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2015-2020)
Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 10. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2021-2026)
Table 11. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026
Table 12. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (US$ Million)
Table 13. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2015-2020)
Table 14. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 15. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2021-2026)
Table 16. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (US$ Million) by Players (2015-2020)
Table 17. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2015-2020)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2019)
Table 19. Date of Key Manufacturers Enter into Induced Pluripotent Stem Cells (iPSCs) Market
Table 20. Global Induced Pluripotent Stem Cells (iPSCs) Top Players Headquarters and Area Served
Table 21. Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service
Table 22. Global Induced Pluripotent Stem Cells (iPSCs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Fujifilm Holding Corporation (CDI) Basic Information List
Table 25. Fujifilm Holding Corporation (CDI) Description and Business Overview
Table 26. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Products, Services and Solutions
Table 27. Revenue (Million US$) in Induced Pluripotent Stem Cells (iPSCs) Business of Fujifilm Holding Corporation (CDI) (2015-2020)
Table 28. Fujifilm Holding Corporation (CDI) Recent Developments
Table 29. Ncardia Basic Information List
Table 30. Ncardia Description and Business Overview
Table 31. Ncardia Induced Pluripotent Stem Cells (iPSCs) Products, Services and Solutions
Table 32. Revenue (Million US$) in Induced Pluripotent Stem Cells (iPSCs) Business of Ncardia (2015-2020)
Table 33. Ncardia Recent Developments
Table 34. Sumitomo Dainippon Pharma Basic Information List
Table 35. Sumitomo Dainippon Pharma Description and Business Overview
Table 36. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Products, Services and Solutions
Table 37. Revenue (Million US$) in Induced Pluripotent Stem Cells (iPSCs) Business of Sumitomo Dainippon Pharma (2015-2020)
Table 38. Sumitomo Dainippon Pharma Recent Developments
Table 39. Astellas Pharma Inc Basic Information List
Table 40. Astellas Pharma Inc Description and Business Overview
Table 41. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Products, Services and Solutions
Table 42. Revenue (Million US$) in Induced Pluripotent Stem Cells (iPSCs) Business of Astellas Pharma Inc (2015-2020)
Table 43. Astellas Pharma Inc Recent Developments
Table 44. Fate Therapeutics, Inc Basic Information List
Table 45. Fate Therapeutics, Inc Description and Business Overview
Table 46. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Products, Services and Solutions
Table 47. Revenue (Million US$) in Induced Pluripotent Stem Cells (iPSCs) Business of Fate Therapeutics, Inc (2015-2020)
Table 48. Fate Therapeutics, Inc Recent Developments
Table 49. Pluricell Biotech Basic Information List
Table 50. Pluricell Biotech Description and Business Overview
Table 51. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Products, Services and Solutions
Table 52. Revenue (Million US$) in Induced Pluripotent Stem Cells (iPSCs) Business of Pluricell Biotech (2015-2020)
Table 53. Pluricell Biotech Recent Developments
Table 54. Cell Inspire Biotechnology Basic Information List
Table 55. Cell Inspire Biotechnology Description and Business Overview
Table 56. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Products, Services and Solutions
Table 57. Revenue (Million US$) in Induced Pluripotent Stem Cells (iPSCs) Business of Cell Inspire Biotechnology (2015-2020)
Table 58. Cell Inspire Biotechnology Recent Developments
Table 59. ReproCELL Basic Information List
Table 60. ReproCELL Description and Business Overview
Table 61. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Products, Services and Solutions
Table 62. Revenue (Million US$) in Induced Pluripotent Stem Cells (iPSCs) Business of ReproCELL (2015-2020)
Table 63. ReproCELL Recent Developments
Table 64. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2015-2020) & (US$ Million)
Table 65. North America Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Country (2015-2020)
Table 66. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2015-2020) & (US$ Million)
Table 67. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Country (2015-2020)
Table 68. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2015-2020) & (US$ Million)
Table 69. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Country (2015-2020) (US$ Million)
Table 70. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2015-2020) & (US$ Million)
Table 71. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Country (2015-2020) (US$ Million)
Table 72. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Players (2015-2020) (US$ Million)
Table 73. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Players (2015-2020) (US$ Million)
Table 74. Induced Pluripotent Stem Cells (iPSCs) Market Trends
Table 75. Induced Pluripotent Stem Cells (iPSCs) Market Drivers
Table 76. Induced Pluripotent Stem Cells (iPSCs) Market Challenges
Table 77. Induced Pluripotent Stem Cells (iPSCs) Market Restriants
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Year-over-Year 2015-2026 & (US$ Million)
Figure 2. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million), 2015 VS 2020VS 2026
Figure 3. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions: 2020 VS 2026
Figure 4. North America Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million) Growth Rate (2015-2026)
Figure 5. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 6. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 7. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 8. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Type in 2020 & 2026
Figure 10. Human iPSCs Market Size (US$ Million) YoY Growth (2015-2026)
Figure 11. Mouse iPSCs Market Size (US$ Million) YoY Growth (2015-2026)
Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Application in 2020 & 2026
Figure 13. Academic Research Market Size (US$ Million) YoY Growth (2015-2026)
Figure 14. Drug Development and Discovery Market Size (US$ Million) YoY Growth (2015-2026)
Figure 15. Toxicity Screening Market Size (US$ Million) YoY Growth (2015-2026)
Figure 16. Regenerative Medicine Market Size (US$ Million) YoY Growth (2015-2026)
Figure 17. Others Market Size (US$ Million) YoY Growth (2015-2026)
Figure 18. Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Top 5 and Top 10 Players Induced Pluripotent Stem Cells (iPSCs) Market Share in 2019
Figure 20. United States Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Rest of Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Keyplayers in Global Induced Pluripotent Stem Cells (iPSCs) Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
Fujifilm Holding Corporation (CDI)Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
